GLP-1 medications get at the heart of addiction: study Dr. Kamal Kant Kohli10 March 2026 9:00 PM ISTResearchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and...
Weight loss drug linked to lower risk of eye disease in patients with diabetes, finds study Dr. Kamal Kant Kohli2 March 2026 11:30 AM ISTThe popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading...
CagriSema Fails to Demonstrate Noninferiority to Tirzepatide for Weight Loss: Phase 3 REDEFINE Trial Dr. Kamal Kant Kohli24 Feb 2026 9:15 AM ISTTopline results from a phase 3 clinical trial compared CagriSema with tirzepatide in patients with obesity. CagriSema is a fixed-dose combination of...
Ixekizumab and tirzepatide combo Improves Skin Clearance and Weight Loss in Psoriasis Patients with Obesity: Study Dr. Kamal Kant Kohli19 Feb 2026 8:45 AM ISTNew findings indicate that in adults with moderate-to-severe plaque psoriasis who are overweight or obese, combined treatment with ixekizumab (Taltz)...
Hormone Therapy May Enhance Tirzepatide-Associated Weight Loss in Postmenopausal Women: The Lancet Dr Riya Dave4 Feb 2026 9:00 PM ISTResearchers have found in a retrospective cohort study that postmenopausal women with obesity treated with tirzepatide experienced greater weight loss...
SURPASS-2- Tirzepatide vs Semaglutide in Type 2 Diabetes Deeksha Bhandari4 Feb 2026 12:30 PM ISTKey Summary: In addition to meeting the primary objective of noninferiority to semaglutide in type 2 diabetes (T2D), tirzepatide, at a dose of...
Tirzepatide Weight-Loss Therapy Not Linked to Depression or Suicidal Risk: Study Finds Medha Baranwal3 Feb 2026 9:00 AM ISTUSA: Researchers have found that once-weekly subcutaneous tirzepatide administered for 72 weeks does not increase the risk of depression in adults...
Tirzepatide Linked to Reduced Risk of Diabetic Retinopathy Among Obese Diabetics, Suggests Study Medha Baranwal2 Feb 2026 8:30 AM ISTUSA: Previous reports have linked GLP-1 receptor agonists with a higher incidence of new diabetic retinopathy. However, a new retrospective study...
India-EU FTA Could Reduce Drug Prices by Up to 20%, Transform Access to Biologics and Devices Susmita Roy29 Jan 2026 11:15 PM ISTNew Delhi: India's Free Trade Agreement (FTA) with the European Union is being projected as a major breakthrough for healthcare, with expectations of...
SURPASS-2: Superior HbA1c and Weight Reduction With Tirzepatide vs. Semaglutide Deeksha Bhandari29 Jan 2026 11:00 AM ISTThe SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already...
Roche's Experimental Obesity Drug Delivers Up to 22.5% Weight Loss in Phase-II Trial sheeba farhat28 Jan 2026 4:46 PM ISTRoche's experimental obesity drug CT-388 reduces appetite and is in the same class as Lilly's market-leading Zepbound, also known as tirzepatide and...
No Link to Suicidal Thoughts: USFDA Seeks Label Change for Popular Weight-Loss Drugs Wegovy, Zepbound sheeba farhat14 Jan 2026 6:57 PM ISTThe warnings, part of their original approval, were based ​on reports of such events observed with a variety of older medicines used or studied ‌for...
